Skip to content

An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

An Observational, Cross-Sectional Study Evaluating the Impact of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07755943
Enrollment
300
Registered
2026-08-10
Start date
2026-05-12
Completion date
2026-08-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generally Healthy Adults Who Are Long-term Supplement Users

Brief summary

This study will evaluate whether dietary supplement use (\> 1 year) is associated with differences in biological age relative to chronological age, as well as differences in metabolic health and functional fitness tests.

Detailed description

Using a cross-sectional study design, information will be obtained by biomarker analysis, questionnaires, physical examination, and physical function from a convenience sample of long-term users of dietary supplements. Comparison data for non-users and single multivitamin/mineral and multiple supplement users will be obtained from the National Health and Nutrition Examination Survey (NHANES).

Interventions

OTHERNo Intervention: Observational Cohort

No intervention: observational cohort

Sponsors

Shaklee Corporation
Lead SponsorINDUSTRY
Biofortis Clinical Research, Inc.
CollaboratorINDUSTRY
Nlumn LLC
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 40 years or older. * Verified long-term Sponsor supplement use (\>1 year). * Willing and able to provide informed consent and comply with study procedures. * Able to fast overnight (\>8 hours) prior to the study visit. * Willing and able to travel to the test site. * Ambulatory and currently free of injury or other physical impairment that hinders mobility. * Willing to use a personal smart phone or computer with internet access and active email address. * Willing to adhere to all study procedures and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information.

Exclusion criteria

* Current or recent (within 6 months) diagnosis of cancer except for non-melanoma skin cancer. * Participant is pregnant or lactating. * Participant has a pacemaker or other implanted electronic device. * Any condition the study staff believes would interfere with the participant's ability to provide informed consent or comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Design outcomes

Primary

MeasureTime frameDescription
Difference between biological and chronological age (years) calculated using a validated biological age calculatorBaseline single assessment for this observational studyDifferences will be compared to an NHANES cohort, where possible.

Secondary

MeasureTime frameDescription
Blood pressure (mm Hg)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Heart rate (beats per minute)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Body weight (kg)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Body mass index (kg/m2)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Waist-to-hip ratioBaseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Body fat (%)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Fat-free body mass (kg)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Grip strength (kg)Single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Lower body strength assessed using the chair stand test (total number of stands)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Flexibility assessed using the sit and reach test (distance in inches reached)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Balance assessed using the one-legged stance test (hold time in seconds)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Quality of life as assessed by the CDC HRQOL-4 questionnaire (overall health rating and number of days)Single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Cognition as assessed by the cognition scale of the Fatigue and Altered Cognition Scale questionnaire (cognition scale total score)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort
Social connection as assessed by the NIH Social Connection and Isolation Panel questionnaire (total score)Baseline single assessment for this observational studyDifferences will be assessed in comparison to an NHANES cohort

Countries

United States

Contacts

CONTACTBiofortis Research Clinical Director
biofortisresearch@mxns.com(630) 617-2000
STUDY_DIRECTORErin Barrett, PhD

Shaklee Corporation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026